• Giacomo Della Marca, Roberto Frusciante, Catello Vollono, Serena Dittoni, Giuliana Galluzzi, Cristina Buccarella, Anna Modoni, Salvatore Mazza, Pietro Attilio Tonali, and Enzo Ricci.
• Department of Neurosciences, Catholic University, Rome, Italy. dellamarca@rm.unicatt.it
• J. Neurol. Sci. 2007 Dec 15;263(1-2):49-53.

ObjectiveTo evaluate the subjective sleep quality, the prevalence of daytime sleepiness and the risk of sleep-related upper airways obstruction in patients with genetically proven Facioscapulohumeral muscular dystrophy (FSHD). FSHD is an autosomal dominant myopathy, characterized by an early involvement of facial and scapular muscles with eventual spreading to pelvic and lower limb muscles.Patients And MethodsForty-six patients were enrolled, 27 women and 19 men, mean age 43.6+/-14.1 years. Study protocol included: a Clinical Severity Scale (CSS) for FSHD, Pittsburgh Sleep Quality Index (PSQI), Italian version of the Epworth Sleepiness Scale (ESS) and the search for clinical predictors of sleep-related airways obstruction.ResultsTwenty-seven patients presented snoring, 12 reported respiratory pauses during sleep. One half (23/46) had PSQI scores above the normal threshold (=5). Correlations were found between the CSS and: the total PSQI score, the components C1 sleep quality, C5 sleep disturbances, C7 daytime dysfunction.ConclusionOur data support the hypothesis that patients with FSHD have an impaired sleep quality, and that this impairment is directly related to the severity of the disease. A systematic polysomnographic evaluation of these patients will be necessary to confirm the presence of sleep disruption and to clarify its pathogenesis.

19 keywords...

hide…